Artivion | CRY - 贸易债权人



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 947.8M
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


贸易债权人 更改 日
Abbott USD 4.68B 439M 2026-03
Accuray USD 43.52M 1.12M 2025-12
AngioDynamics USD 35.39M 3.51M 2025-09
Artivion USD 20.87M 2.53M 2026-06
AtriCure USD 78.74M 8.68M 2026-06
Baxter International USD 1.03B 52M 2026-06
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Boston Scientific USD 1.23B 90M 2026-06
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Inogen USD 21.22M 684K 2025-09
Integra LifeSciences USD 82.64M 5.31M 2026-06
J&J USD 9.22B 1.24B 2026-06
Mesa Laboratories USD 5.25M 163K 2025-12
Orthofix International USD 63.53M 8.84M 2026-06
Pfizer USD 4.58B 75M 2026-06
ResMed USD 308.92M 35.62M 2026-06
Stryker USD 1.59B 207M 2026-03
Tandem Diabetes Care USD 64.13M 4.27M 2026-06
Teleflex USD 143.29M 335K 2026-06
Terumo JPY 79.79B 9.96B 2026-06
Trinity Biotech USD 11.48M 18.88M 2025-12